Trimethoprim-Sulfamethoxazole in the Treatment of Typhoid and Paratyphoid Fevers

Authors:
  • MSMerrill J. Snyder
    Merrill J. Snyder
  • JPJose Perroni
    Jose Perroni
  • OGOscar Gonzalez
    Oscar Gonzalez
  • CPCarmen Palomino
    Carmen Palomino
  • CGCesar Gonzalez
    Cesar Gonzalez
  • SMStanley Music
    Stanley Music
  • HDHerbert L. DuPont
    Herbert L. DuPont
  • RHRichard B. Hornick
    Richard B. Hornick
  • TWTheodore E. Woodward
    Theodore E. Woodward

Abstract
A trial was conducted in naturally-occurring disease to compare the efficacy of treatment with trimethoprim-sulfamethoxazole (TMP-SMZ) with oral chloramphenicol. The majority of patients treated with TMP-SMZ (79%) responded just as well as did those treated with oral chloramphenicol, as measured by time of disappearance of fever after therapy. Seven patients treated with TMP-SMZ, however, failed to respond after 11 or more days of treatment. Neither levels of drug in serum nor in vitro sensitivity tests of the isolated $ISalmonella$N could account for the slow response of these patients to TMP-SMZ.